Insulin Market in Europe 2015-2019

9
www.technavio.com enquiry@technavio .com Insulin Market in Europe 2015-2019

Transcript of Insulin Market in Europe 2015-2019

Page 1: Insulin Market in Europe 2015-2019

[email protected]

Insulin Market in Europe 2015-2019

Page 2: Insulin Market in Europe 2015-2019

Covered in this Report• The report covers the present scenario and the

growth prospects of the insulin market in Europe for the period 2015-2019.

• To calculate the market size, we consider revenue generated from the sales of various insulin used for the treatment of diabetes.

• Technavio's report, Insulin Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

• The report covers the landscape of the insulin market in Europe and its growth prospects in the coming years.

• The report includes a discussion of the key vendors operating in this market.

Insulin Market in Europe 2015-2019

USA – CANADA – UK – CHINA – INDIA

Page 3: Insulin Market in Europe 2015-2019

Market Overview

• Insulin is a hormone produced by the beta cells of the pancreas; insulin has a key role in regulating the blood glucose levels.

• It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the food for energy or to store glucose for future use.

• The beta cells of the pancreas of people with type 1 diabetes do not produce sufficient insulin to regulate blood glucose level; therefore, they need to intake insulin daily. On the other hand, people with type 2 diabetes or gestational diabetes need doses of insulin together with other medication.

• Technavio's analysts forecast the insulin market in Europe to grow at a CAGR of 6.50% over the period 2014-2019.

To know more aboutInsulin Market in Europe

2015-2019,please mail us at

[email protected]

USA – CANADA – UK – CHINA – INDIA

Page 4: Insulin Market in Europe 2015-2019

Key Vendors and Regions

• Elli Lilly

• Novo Nordisk

• Sanofi

• Biodel

• Boehringer Ingelheim

• Bristol-Myers Squibb

• Diamyd Medical

• DiaVacs

View Our Report: Insulin Market in Europe 2015-2019

• Europe

Vendors Regions

USA – CANADA – UK – CHINA – INDIA

Page 5: Insulin Market in Europe 2015-2019

Key Findings• The key players in the market are extending their support to academic institutions for the

R&D of innovative products for diabetes care.

• For instance, Sanofi have collaborated with academic institutions such as the Joslin Diabetes Center, Helmholtz Zentrum, and Charite to support R&D activities in the diabetes care segment.

• The recent collaboration of Sanofi and Gubra to discover new targets for diabetes was based on the collaboration between the University of Copenhagen, Gubra and Gentofte Hospital.

• This consortium, in turn, received funds from the Danish National Advanced Technology Foundation.

• In 2008, Novo Nordisk collaborated with the Stem Cell Center at Lund University and Cellartis to develop a cell therapy product consisting of insulin-producing cells.

• Such collaborations enable the consolidation of research expertise of academic institutions with the marketing intelligence of pharma companies besides providing funds to conduct trial studies.

USA – CANADA – UK – CHINA – INDIA

Page 6: Insulin Market in Europe 2015-2019

Key Questions Answered in Our Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Have a question of your own about this report?

Ask our Analysts

USA – CANADA – UK – CHINA – INDIA

Page 7: Insulin Market in Europe 2015-2019

• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.

• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.

About Technavio

Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo

USA – CANADA – UK – CHINA – INDIA

Page 9: Insulin Market in Europe 2015-2019

Thank You!

Mail us at: [email protected] can visit us at:www.technavio.com

USA – CANADA – UK – CHINA – INDIA